Revelation Biosciences Inc Cash Flow Reinvestment Rate
Revelation Biosciences Inc cash flow reinvestment rate. Revelation Biosciences Inc (REVB) has a Cash Flow Reinvestment Rate of 2.22x as of December 2018, reinvesting $18.70 Million (capex $349.00K plus investments $-18.35 Million) from operating cash flow of $8.43 Million. Explore REVB debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Revelation Biosciences Inc (2015–2019)
Cash flow reinvestment rate of Revelation Biosciences Inc from 2015 to 2019. Historical reinvestment intensity for Revelation Biosciences Inc across 5 annual periods. Explore Revelation Biosciences Inc (REVB) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Revelation Biosciences Inc Cash Flow Reinvestment Rate by Year (2015–2019)
Revelation Biosciences Inc cash flow reinvestment rate by year from 2015 to 2019. Year-by-year capital reinvestment analysis for Revelation Biosciences Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Revelation Biosciences Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 8.98x | $369.13 Million | $41.09 Million | $526.00K | ▼ -1.0% |
| 2018 | 9.08x | $295.71 Million | $32.58 Million | $861.00K | ▼ -12.8% |
| 2017 | 10.41x | $252.40 Million | $24.25 Million | $804.00K | ▼ -38.8% |
| 2016 | 17.01x | $197.25 Million | $11.60 Million | $582.00K | ▲ +511.2% |
| 2015 | 2.78x | $32.27 Million | $11.60 Million | $582.00K | — |